GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OTCPK:CAMRF) » Definitions » 5-Year Yield-on-Cost %

CAMRF (Camurus AB) 5-Year Yield-on-Cost % : 0.00 (As of Dec. 15, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Camurus AB 5-Year Yield-on-Cost %?

Camurus AB's yield on cost for the quarter that ended in Sep. 2024 was 0.00.


The historical rank and industry rank for Camurus AB's 5-Year Yield-on-Cost % or its related term are showing as below:



CAMRF's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.57
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Camurus AB's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Camurus AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Camurus AB's 5-Year Yield-on-Cost % falls into.



Camurus AB 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Camurus AB is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Camurus AB  (OTCPK:CAMRF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Camurus AB 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Camurus AB's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

From GuruFocus

Q1 2021 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q4 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 02-28-2024

Q1 2024 Camurus AB Earnings Call Transcript

By GuruFocus Research 05-09-2024

Q1 2022 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Full Year 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Half Year 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q3 2019 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Camurus AB Special Call Transcript

By GuruFocus Research 03-02-2024

Q1 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024